date:Oct 26, 2012
.
The symptoms associated with the deaths include loss of consciousness, cardiac arrest, arrhythmia and drug toxicity. It's unclear if the dates of the reports approximately coincide with the actual deaths, and the public data includes scant details on the circumstances surrounding the fatalities.
FDA is investigating those five deaths plus a report of a non-fatal heart attack, though Burgess could give no timeline on completing such probes.
The records were released late last month to Wen